Jefferies Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-287,400
Closed -$15M 1355
2020
Q2
$15M Buy
+287,400
New +$14.8M 0.18% 81
2019
Q2
Sell
-34,700
Closed -$1.67M 2546
2019
Q1
$1.67M Buy
+34,700
New +$1.74M 0.01% 1002
2016
Q3
Sell
-8,100
Closed -$632K 2245
2016
Q2
$632K Sell
8,100
-11,900
-60% -$949K ﹤0.01% 1328
2016
Q1
$1.64M Buy
+20,000
New +$1.63M 0.01% 939
2015
Q3
Sell
-20,500
Closed -$1.72M 2343
2015
Q2
$1.72M Buy
20,500
+1,600
+8% +$141K 0.01% 994
2015
Q1
$1.71M Buy
+18,900
New +$1.63M 0.01% 823
2014
Q4
Sell
-20,700
Closed -$1.55M 1966
2014
Q3
$1.55M Buy
+20,700
New +$1.51M 0.01% 820
2013
Q3
Sell
-8,300
Closed -$392K 1941
2013
Q2
$392K Buy
+8,300
New +$379K ﹤0.01% 1172

Other funds holding CAH

Jefferies Group's CAH Position: Q4 2021 in Review

Jefferies Group sold out of Cardinal Health (CAH) in Q4 2021, closing a stake of 10,860 shares — an estimated $537K sold.

Jefferies Group first reported a position in CAH in Q2 2013 and held it in 28 quarters. The position peaked at $4.87M in Q2 2016. 780 funds tracked by Wall St. Rank hold CAH as of Q4 2021.

  • Jefferies Group reported no remaining Cardinal Health position as of Q4 2021 after selling out during the quarter.
  • Jefferies Group sold 10,860 Cardinal Health shares in Q4 2021, an estimated $537K.
  • Jefferies Group first reported a position in Cardinal Health in Q2 2013 and held it in 28 quarters.
  • Jefferies Group's Cardinal Health position peaked at $4.87M in Q2 2016.
  • 780 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.